Encapsulated Stem Cells Loaded With Hyaluronidase-expressing Oncolytic Virus for Brain Tumor Therapy

Stupp, 2005, Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, N Engl J Med, 352, 987, 10.1056/NEJMoa043330 Alonso, 2007, ICOVIR-5 shows E2F1 addiction and potent antiglioma effect in vivo, Cancer Res, 67, 8255, 10.1158/0008-5472.CAN-06-4675 Parker, 2009, Oncolytic viral therapy of malignant glioma, Neurotherapeutics, 6, 558, 10.1016/j.nurt.2009.04.011 Chiocca, 2004, A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting, Mol Ther, 10, 958, 10.1016/j.ymthe.2004.07.021 Chiocca, 2008, A phase I trial of Ad.hIFN-beta gene therapy for glioma, Mol Ther, 16, 618, 10.1038/sj.mt.6300396 Lang, 2003, Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results, J Clin Oncol, 21, 2508, 10.1200/JCO.2003.21.13.2508 Sironen, 2011, Hyaluronan in human malignancies, Exp Cell Res, 317, 383, 10.1016/j.yexcr.2010.11.017 Park, 2008, Role of hyaluronan in glioma invasion, Cell Adh Migr, 2, 202, 10.4161/cam.2.3.6320 Guedan, 2010, Hyaluronidase expression by an oncolytic adenovirus enhances its intratumoral spread and suppresses tumor growth, Mol Ther, 18, 1275, 10.1038/mt.2010.79 Shuster, 2002, Hyaluronidase reduces human breast cancer xenografts in SCID mice, Int J Cancer, 102, 192, 10.1002/ijc.10668 Wakimoto, 2012, Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells, Neuro Oncol, 14, 132, 10.1093/neuonc/nor195 Wakimoto, 2009, Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors, Cancer Res, 69, 3472, 10.1158/0008-5472.CAN-08-3886 Smith, 2014, Oncolytic viral therapy: targeting cancer stem cells, Oncolytic Virother, 2014, 21 Markert, 2009, Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM, Mol Ther, 17, 199, 10.1038/mt.2008.228 Mohyeldin, 2012, Gene and viral therapy for glioblastoma: a review of clinical trials and future directions, Cancer J, 18, 82, 10.1097/PPO.0b013e3182458b13 Kaur, 2012, Oncolytic HSV-1 virotherapy: clinical experience and opportunities for progress, Curr Pharm Biotechnol, 13, 1842, 10.2174/138920112800958814 Ahmed, 2011, Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma, Mol Ther, 19, 1714, 10.1038/mt.2011.100 Ma, 2004, CNS stem and progenitor cell differentiation into functional neuronal circuits in three-dimensional collagen gels, Exp Neurol, 190, 276, 10.1016/j.expneurol.2003.10.016 Potter, 2008, Biomimetic material systems for neural progenitor cell-based therapy, Front Biosci, 13, 806, 10.2741/2721 Hansen, 2010, A 3-dimensional extracellular matrix as a delivery system for the transplantation of glioma-targeting neural stem/progenitor cells, Neuro Oncol, 12, 645, 10.1093/neuonc/noq002 Prestwich, 2011, Hyaluronic acid-based clinical biomaterials derived for cell and molecule delivery in regenerative medicine, J Control Release, 155, 193, 10.1016/j.jconrel.2011.04.007 Kauer, 2012, Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas, Nat Neurosci, 15, 197, 10.1038/nn.3019 Duebgen, 2014, Stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy, J Natl Cancer Inst, 106, dju090, 10.1093/jnci/dju090 Stuckey, 2014, Engineering toxin-resistant therapeutic stem cells to treat brain tumors, Stem Cells Pluen, 2001, Role of tumor-host interactions in interstitial diffusion of macromolecules: cranial vs. subcutaneous tumors, Proc Natl Acad Sci USA, 98, 4628, 10.1073/pnas.081626898 Pedron, 2013, Regulation of glioma cell phenotype in 3D matrices by hyaluronic acid, Biomaterials, 34, 7408, 10.1016/j.biomaterials.2013.06.024 Maria, 2008, Targeting hyaluronan interactions in spinal cord astrocytomas and diffuse pontine gliomas, J Child Neurol, 23, 1214, 10.1177/0883073808321771 Kuriyama, 2000, Pretreatment with protease is a useful experimental strategy for enhancing adenovirus-mediated cancer gene therapy, Hum Gene Ther, 11, 2219, 10.1089/104303400750035744 McKee, 2006, Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector, Cancer Res, 66, 2509, 10.1158/0008-5472.CAN-05-2242 Ganesh, 2008, Intratumoral coadministration of hyaluronidase enzyme and oncolytic adenoviruses enhances virus potency in metastatic tumor models, Clin Cancer Res, 14, 3933, 10.1158/1078-0432.CCR-07-4732 Mok, 2007, Matrix metalloproteinases-1 and -8 improve the distribution and efficacy of an oncolytic virus, Cancer Res, 67, 10664, 10.1158/0008-5472.CAN-07-3107 Thaci, 2013, Anti-angiogenic therapy increases intratumoral adenovirus distribution by inducing collagen degradation, Gene Ther, 20, 318, 10.1038/gt.2012.42 Jin, 2009, The effect of hyaluronic Acid on the invasiveness of malignant glioma cells: comparison of invasion potential at hyaluronic Acid hydrogel and matrigel, J Korean Neurosurg Soc, 46, 472, 10.3340/jkns.2009.46.5.472 Boregowda, 2006, Expression of hyaluronan in human tumor progression, J Carcinog, 5, 2, 10.1186/1477-3163-5-2 Toole, 2004, Hyaluronan: from extracellular glue to pericellular cue, Nat Rev Cancer, 4, 528, 10.1038/nrc1391 Kim, 2005, Hyaluronic acid induces osteopontin via the phosphatidylinositol 3-kinase/Akt pathway to enhance the motility of human glioma cells, Cancer Res, 65, 686, 10.1158/0008-5472.686.65.3 Shah, 2005, Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression, Ann Neurol, 57, 34, 10.1002/ana.20306 Kranzler, 2009, Stem cells as delivery vehicles for oncolytic adenoviral virotherapy, Curr Gene Ther, 9, 389, 10.2174/156652309789753347 Ahmed, 2013, A preclinical evaluation of neural stem cell-based cell carrier for targeted antiglioma oncolytic virotherapy, J Natl Cancer Inst, 105, 968, 10.1093/jnci/djt141 Lee, 2009, Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells, Clin Cancer Res, 15, 4925, 10.1158/1078-0432.CCR-08-3076 Abumaree, 2012, Immunosuppressive properties of mesenchymal stem cells, Stem Cell Rev, 8, 375, 10.1007/s12015-011-9312-0 Kanai, 2012, Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells, J Natl Cancer Inst, 104, 42, 10.1093/jnci/djr509 Baumgartner, 1998, The impact of extracellular matrix on chemoresistance of solid tumors–experimental and clinical results of hyaluronidase as additive to cytostatic chemotherapy, Cancer Lett, 131, 1, 10.1016/S0304-3835(98)00204-3 Shah, 2012, Mesenchymal stem cells engineered for cancer therapy, Adv Drug Deliv Rev, 64, 739, 10.1016/j.addr.2011.06.010 Somoza, 2012, Cell therapy using induced pluripotent stem cells or somatic stem cells: this is the question, Curr Stem Cell Res Ther, 7, 191, 10.2174/157488812799859865 Rojas, 2010, Minimal RB-responsive E1A promoter modification to attain potency, selectivity, and transgene-arming capacity in oncolytic adenoviruses, Mol Ther, 18, 1960, 10.1038/mt.2010.173 Cascallo, 2006, Deletion of VAI and VAII RNA genes in the design of oncolytic adenoviruses, Hum Gene Ther, 17, 929, 10.1089/hum.2006.17.929 Martinez-Quintanilla, 2013, Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors, Stem Cells, 31, 1706, 10.1002/stem.1355 Sasportas, 2009, Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy, Proc Natl Acad Sci USA, 106, 4822, 10.1073/pnas.0806647106 Hingtgen, 2013, Real-time multi-modality imaging of glioblastoma tumor resection and recurrence, J Neurooncol, 111, 153, 10.1007/s11060-012-1008-z